Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
NUXP SEC Suspension:
http://www.sec.gov/litigation/suspensions/2014/34-72364.pdf
Order:
http://www.sec.gov/litigation/suspensions/2014/34-72364-o.pdf
Admin Proceeding:
http://www.sec.gov/litigation/admin/2014/34-72365.pdf
NUXP .0016 http://www.profitspi.com/stock/view.aspx?v=price-and-chart&p=18484&i=NUXP&pv=recent-symbols&pp=NUXP#&&vs=634994213954945404
http://www.nurxpharmaceuticals.com/
Still on watch for the day... IF>>> it happens, .002bid with steady per-minute sales.
<0o>ing
sc
NUXP 3/06/13 190kvs0k_vol10dayavg http://www.profitspi.com/stock/view.aspx?v=price-and-chart&p=18484&i=NUXP&pv=recent-symbols&pp=NUXP#&&vs=634989740003295940
NUXP Security Details
Share Structure
Shares Outstanding 23,444,234 a/o Aug 19, 2010
Looks like the time could be now for NUXP jmurfk! .02x.05
QUANTRX BIOMEDICAL CORP FILES (8-K) Disclosing Entry into a Material Definitive Agreement Edgar Online "Glimpses"
Item 1.01 Entry into a Material Definitive Agreement.
On July 7, 2011 , QuantRx Biomedical Corporation (the "Company"), NuRx Pharmaceuticals, Inc. ("NuRx") and William H. Fleming ("Fleming") entered into a Settlement Agreement and Release ("Release"). The parties entered into the Release to resolve all disputes between the parties relating to a law suit brought against the Company and Fleming by NuRx in the Court of Chancery of the State of Delaware (the "Complaint") relating to QN Diagnostics, LLC , a joint venture between NuRx and the Company ("QND").
Pursuant to the terms of the Release, the Company transferred its entire membership interest in QND to NuRx, including all assets held by the Company relating to QND, for and in consideration for the issuance to the Company of 12.0 million shares of common stock of NuRx (the "Settlement Shares"). As a result of the issuance of the Settlement Shares and the terms of the Release, the Company will hold an approximate 25% equity interest in NuRx, and the Company has no further contractual obligations or liabilities associated with its former interest in QND. The Release also requires NuRx to bring its filings with the Securities and Exchange Commission ("SEC") current by March 31, 2012 , and provides the Company with certain additional rights, including the preemptive right to acquire additional shares of NuRx common stock in connection with a future financing, the right to register the Settlement Shares, and the right to elect one director to NuRx for a period of three years from the date of execution of the Release.
As a result of the execution of the Release, all claims asserted by either party against any other party to the Release, whether related to the Complaint or QND, are terminated and the Complaint is dismissed with prejudice. In addition, the four million warrants to purchase shares of common stock of the Company held by NuRx are surrendered, terminated and are of no further force and effect. A copy of the Release is attached to this Current Report on Form 8-K as Exhibit 99.1.
I think so. Came down on just small volume. Matter of time on this one.
Just noticed that they have a new website under construction also!
http://www.nurxpharmaceuticals.com/
Real nice. Great value at this PPS! Looking for a nice comeback next week.
recent restructuring going on eh?
Effective August 6, 2009, Matthew Borenzweig resigned from the Board of Directors of NuRx Pharmaceuticals, Inc.
I'll do some DD and get back to you when I find out...
I'll add myself as the moderator if you don't mind LOL
Q
Looks like they are funding another Pharma company?
Anyone know anything about this company?
Press Release Source: Resources Ltd.; Hollund Industrial, Inc.
Featured Stocks on Today's Edition of WallSt.net's 3-Minute Press Show: BSGC, NUXP, KYUS, BABB, EMXC, CEM, HLLD
Wednesday May 14, 7:00 am ET
NEW YORK, May 14 /PRNewswire/ -- WallSt.net's 3-Minute Press Show is a daily video program hosted by WallSt.net reporter, Tracee Tolentino.
Shows air Monday through Friday on:
http://tv.wallst.net/3-min-press/3-min-press.php.
WallSt.net's 3-Minute Press Show features in-depth interviews with public company executives on their company and most recent press releases. The show is designed to provide viewers with insight into a company's most recent press release, and its impact on the company's growth.
The following executives were interviewed on today's show:
-- Darin Myman, Chief Executive Officer of BigString Corp.
(OTC Bulletin Board: BSGC - News; http://www.bigstring.com)
-- Dr. Harin Padma-Nathan, Chief Executive Officer of NuRx
Pharmaceuticals, Inc.
(OTC Bulletin Board: NUXP - News; http://www.nurxpharmaceuticals.com)
-- Steven Eversole, Chief Executive Officer of Kentucky USA Energy, Inc.
(OTC Bulletin Board: KYUS - News; http://www.kusaenergy.com)
-- Tony Cervini, Director of Franchise Sales for BAB, Inc.
(OTC Bulletin Board: BABB - News; http://www.babcorp.com)
-- Roxanna Weber, Chief Executive Officer of eMax Holdings Corp.
(Pink Sheets: EMXC - News; http://www.emaxcorp.com)
-- Garfield MacVeigh, President and CEO of Constantine Metal Resources
Ltd.
(TSX.V: CEM) (http://www.constantinemetals.com/)
-- Mike Lacy, President and Chief Executive Officer of Hollund
Industrial, Inc.
(Pink Sheets: HLLD - News; http://www.hollundindustrial.com)
About WallStreet Direct, Inc.
WallStreet Direct, Inc. a wholly-owned subsidiary of Financial Media Group, Inc. (OTC Bulletin Board: FNGP - News), owns and operates WallSt.net (http://www.wallst.net), a leading source of up-to-the-minute business news, comprehensive financial tools and original multimedia content for the investment community. In addition to WallSt.net, WallStreet Direct owns and operates WallStRadio (http://radio.wallst.net) an online hub for business podcasts from well-known business news personalities and publishers; and WallSt TV (http://tv.wallst.net), an online hub for business and finance video programming. We have received four hundred ninety five dollars from BigString Corp. for press release dissemination services. To read our full disclaimer, and for a complete list of our advertisers, and advertising relationships, visit http://www.wallst.net/disclaimer/disclaimer.php.
Contact
WallSt.net
800-4-WALLST
Followers
|
3
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
19
|
Created
|
11/14/06
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |